Cargando…
Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
Autores principales: | Yuan, Tingting, Tang, Honglin, Xu, Xiaojie, Shao, Jingjing, Wu, Gaojun, Cho, Young-Chang, Ping, Yuan, Liang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344939/ https://www.ncbi.nlm.nih.gov/pubmed/37456830 http://dx.doi.org/10.1016/j.isci.2023.107251 |
Ejemplares similares
-
Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022) -
A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders
por: Xu, Xiaojie, et al.
Publicado: (2022) -
Genome-editing prodrug: Targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease
por: Yan, Xiaojie, et al.
Publicado: (2021) -
Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)